Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYB5D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PHF20L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLT8D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCN2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927164 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PARP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JAKMIP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACVR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP2K4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFRP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADIPOR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP9A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on